Literature DB >> 15263087

Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells.

Jaejoon Won1, Seungwoo Chang, Sangtaek Oh, Tae Kook Kim.   

Abstract

Activation of telomerase is crucial for cells to gain immortality. Most normal human somatic cells have a limited proliferative life span, and expression of the rate-limiting telomerase catalytic subunit, known as human telomerase reverse transcriptase (hTERT), has been believed to be tightly repressed. This model of hTERT regulation is challenged by the recent identification of the induction of hTERT in normal cycling human fibroblasts during their transit through S phase. Here we show the small-molecule-based identification of the assembly and disassembly of E2F-pocket protein-histone deacetylase (HDAC) complex as a key mechanistic basis for the repression and activation of hTERT in normal human cells. A cell-based chemical screen was used to identify a small molecule, CGK1026, that derepresses hTERT expression. CGK1026 inhibits the recruitment of HDAC into E2F-pocket protein complexes assembled on the hTERT promoter. Chromatin immunoprecipitation analysis reveals dynamic alterations in hTERT promoter occupancy by E2F and pocket proteins according to the cell cycle-dependent regulation of hTERT. Dominant-negative or protein-knockout strategies to disrupt the assembly of E2F-pocket protein-HDAC complex derepress hTERT and telomerase activity. Taken together with the results on the regulatory function of these complexes in cellular senescence and tumorigenesis, our findings suggest that dynamic assembly of E2F-pocket protein-HDAC complex plays a central role in the regulation of hTERT in a variety of proliferative conditions (e.g., normal cycling, senescent, and tumor cells).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15263087      PMCID: PMC509202          DOI: 10.1073/pnas.0401801101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.

Authors:  S Oh; Y H Song; U J Kim; J Yim; T K Kim
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

Review 2.  Historical claims and current interpretations of replicative aging.

Authors:  Woodring E Wright; Jerry W Shay
Journal:  Nat Biotechnol       Date:  2002-07       Impact factor: 54.908

3.  Telomerase extracurricular activities.

Authors:  Sandy Chang; Ronald A DePinho
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

Review 4.  Cellular senescence as a tumor-suppressor mechanism.

Authors:  J Campisi
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Authors:  Laura L Smith; Hilary A Coller; James M Roberts
Journal:  Nat Cell Biol       Date:  2003-05       Impact factor: 28.824

Review 6.  Stem cells, telomerase and dyskeratosis congenita.

Authors:  Philip J Mason
Journal:  Bioessays       Date:  2003-02       Impact factor: 4.345

7.  Trichostatin A, a histone deacetylase inhibitor, activates the IGFBP-3 promoter by upregulating Sp1 activity in hepatoma cells: alteration of the Sp1/Sp3/HDAC1 multiprotein complex.

Authors:  Hong Seok Choi; Je Ho Lee; Jong Gu Park; Young Ik Lee
Journal:  Biochem Biophys Res Commun       Date:  2002-08-30       Impact factor: 3.575

8.  Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.

Authors:  Jaejoon Won; Jeongbin Yim; Tae Kook Kim
Journal:  FASEB J       Date:  2002-10-04       Impact factor: 5.191

9.  Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.

Authors:  Jaejoon Won; Jeongbin Yim; Tae Kook Kim
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

10.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

View more
  10 in total

1.  HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.

Authors:  Xuefeng Liu; Jeffrey Roberts; Aleksandra Dakic; Yiyu Zhang; Richard Schlegel
Journal:  Virology       Date:  2008-03-26       Impact factor: 3.616

2.  Differential cis-regulation of human versus mouse TERT gene expression in vivo: identification of a human-specific repressive element.

Authors:  Izumi Horikawa; Y Jeffrey Chiang; Tricia Patterson; Lionel Feigenbaum; Sun-Hee Leem; Eriko Michishita; Vladimir Larionov; Richard J Hodes; J Carl Barrett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

3.  An oncolytic adenovirus controlled by a modified telomerase promoter is attenuated in telomerase-negative cells, but shows reduced activity in cancer cells.

Authors:  S Bortolanza; C Qian; M G Kramer; C Gomar; J Prieto; F Farinati; R Hernandez-Alcoceba
Journal:  J Mol Med (Berl)       Date:  2005-06-23       Impact factor: 4.599

4.  HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300.

Authors:  Michael A James; John H Lee; Aloysius J Klingelhutz
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

5.  A quantitative high-throughput screen identifies potential epigenetic modulators of gene expression.

Authors:  Ronald L Johnson; Wenwei Huang; Ajit Jadhav; Christopher P Austin; James Inglese; Elisabeth D Martinez
Journal:  Anal Biochem       Date:  2007-12-25       Impact factor: 3.365

6.  RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.

Authors:  Sara Selig; Karin Weiss; Nadra Samra; Shir Toubiana; Hilde Yttervik; Aya Tzur-Gilat; Ilham Morani; Chen Itzkovich; Liran Giladi; Kamal Abu Jabal; John Z Cao; Lucy A Godley; Adi Mory; Hagit Baris Feldman; Kristian Tveten
Journal:  J Hum Genet       Date:  2021-05-13       Impact factor: 3.172

Review 7.  Telomeres: history, health, and hallmarks of aging.

Authors:  Deepavali Chakravarti; Kyle A LaBella; Ronald A DePinho
Journal:  Cell       Date:  2021-01-14       Impact factor: 41.582

8.  Oncolytic adenoviruses: A thorny path to glioma cure.

Authors:  I V Ulasov; A V Borovjagin; B A Schroeder; A Y Baryshnikov
Journal:  Genes Dis       Date:  2014-12

9.  Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene.

Authors:  Lynda Li Song; Larissa Ponomareva; Hui Shen; Xin Duan; Fatouma Alimirah; Divaker Choubey
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

10.  An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA.

Authors:  Yoshiko Maida; Mami Yasukawa; Miho Furuuchi; Timo Lassmann; Richard Possemato; Naoko Okamoto; Vivi Kasim; Yoshihide Hayashizaki; William C Hahn; Kenkichi Masutomi
Journal:  Nature       Date:  2009-08-23       Impact factor: 49.962

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.